We are live on ! Find out more
OA

Operose Advisors Portfolio holdings

AUM $517M Turnover 40.26%
1-Year Est. Return 24.68%
This Fund
S&P 500
This Quarter Est. Return
+10.82%
1 Year Est. Return
+24.68%
3 Year Est. Return
+68.8%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$250M
AUM Growth
-$2.65M
Cap. Flow
-$27M
Cap. Flow %
-10.8%
Top 10 Hldgs %
66.7%
Holding
779
New
26
Increased
72
Reduced
220
Closed
182
Avg Time Held
1 year
Top 10 Avg Time Held
1.5 years
Top 20 Avg Time Held
1.5 years
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
IHI icon
526
iShares US Medical Devices ETF
IHI
$3.73B
$2.05K ﹤0.01%
38
-6,780
-99% -$331K
2023 Q3
1 quarter
CLF icon
527
Cleveland-Cliffs
CLF
$6.91B
$2.04K ﹤0.01%
100
– –
2023 Q3
1 quarter
SSYS icon
528
Stratasys
SSYS
$608M
$1.97K ﹤0.01%
138
-12
-8% -$140
2023 Q1
3 quarters
PLUG icon
529
Plug Power
PLUG
$1.93B
$1.9K ﹤0.01%
423
+23
+6% +$121
2023 Q1
3 quarters
XP icon
530
XP
XP
$14.8B
$1.59K ﹤0.01%
61
– –
2023 Q3
1 quarter
MTTR icon
531
DELISTED
Matterport, Inc. Class A Common Stock
MTTR
$1.5K ﹤0.01%
557
-43
-7% -$103
2023 Q1
3 quarters
WIT icon
532
Wipro
WIT
$19.3B
$1.36K ﹤0.01%
490
– –
2023 Q3
1 quarter
LMND icon
533
Lemonade
LMND
$3.42B
$1.29K ﹤0.01%
80
– –
2022 Q4
4 quarters
NICE icon
534
Nice
NICE
$6.57B
$1.2K ﹤0.01%
6
– –
2023 Q3
1 quarter
FTRE icon
535
Fortrea Holdings
FTRE
$2.14B
$1.19K ﹤0.01%
34
– –
2023 Q3
1 quarter
XRN icon
536
Chiron Real Estate Inc
XRN
$402M
$1.11K ﹤0.01%
20
– –
2023 Q3
1 quarter
LICY icon
537
DELISTED
Li-Cycle Holdings Corp.
LICY
$1.03K ﹤0.01%
+221
New +$2.51K
2023 Q4
0 quarters
MCS icon
538
Marcus Corp
MCS
$864M
$1.01K ﹤0.01%
69
– –
2021 Q4
8 quarters
EGHT icon
539
8x8 Inc
EGHT
$280M
$945 ﹤0.01%
250
– –
2022 Q3
5 quarters
BVN icon
540
Compañía de Minas Buenaventura
BVN
$7.73B
$899 ﹤0.01%
59
– –
2023 Q3
1 quarter
NTES icon
541
NetEase
NTES
$80.7B
$838 ﹤0.01%
9
– –
2023 Q3
1 quarter
SKM icon
542
SK Telecom
SKM
$12.3B
$813 ﹤0.01%
38
– –
2023 Q3
1 quarter
MNDY icon
543
monday.com
MNDY
$3.82B
$751 ﹤0.01%
4
– –
2023 Q3
1 quarter
AZN icon
544
AstraZeneca
AZN
$257B
$674 ﹤0.01%
5
-498
-99% -$64.7K
2021 Q4
8 quarters
HIT icon
545
DELISTED
HITACHI LTD ADR (10COM)NEW
HIT
$578 ﹤0.01%
4
– –
2023 Q3
1 quarter
KSS icon
546
Kohl's
KSS
$2.45B
$574 ﹤0.01%
+20
New +$469
2023 Q4
0 quarters
UAL icon
547
United Airlines
UAL
$31.2B
$536 ﹤0.01%
13
– –
2021 Q4
8 quarters
JO
548
DELISTED
iPath Bloomberg Coffee Subindex Total Return ETN due June 24, 2038
JO
$468 ﹤0.01%
25
– –
2021 Q4
8 quarters
KW icon
549
DELISTED
Kennedy-Wilson Holdings
KW
$458 ﹤0.01%
37
– –
2022 Q4
4 quarters
AVNS icon
550
DELISTED
Avanos Medical
AVNS
$449 ﹤0.01%
20
– –
2021 Q4
8 quarters

Similar funds

Operose Advisors's Q4 2023 Portfolio in Review

As of Q4 2023, Operose Advisors held 779 positions worth $250M, down 1% from $253M the previous quarter. Its ten largest holdings account for 67% of the portfolio.

Operose Advisors withdrew a net $27M in Q4 2023, closing 182 positions and reducing 220 holdings. Its most notable exit was JPMorgan BetaBuilders Japan ETF, an estimated $349K position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 81% of assets, up from 77% a quarter earlier, followed by Financials and Technology.

Against the trend, Operose Advisors opened a new position in State Street SPDR Bloomberg 1-3 Month T-Bill ETF worth $772K.

  • Operose Advisors's largest Q4 2023 buy was State Street SPDR Bloomberg 1-3 Month T-Bill ETF: 8,443 shares worth $772K.
  • Operose Advisors added most to Vanguard Morningstar Total Stock Market ETF in Q4 2023, an estimated $4.1M increase.
  • Operose Advisors's biggest Q4 2023 reduction was Vanguard High Dividend Yield ETF, cutting an estimated $4.55M.
  • Operose Advisors fully exited JPMorgan BetaBuilders Japan ETF in Q4 2023, selling an estimated $349K.
  • Operose Advisors's ten largest holdings make up 67% of its $250M portfolio in Q4 2023.
  • Operose Advisors opened 26 new positions and closed 182 in Q4 2023.
  • Operose Advisors's portfolio value fell 1% quarter-over-quarter to $250M.

Based on Operose Advisors's 13F filing for Q4 2023, filed 12 Feb 2024.